Cyclic Vomiting Syndrome in Children
AJGH 2:doi:10.33552/AJGH.2020, Al-Ansari, N., 2020
Vestibular Migraine
BMJ 366:L4213, Li, V.,et al, 2019
Abdominal Migraine
BMJ 360;k179, Angus-Leppan, H.,et al, 2018
Positive Persistent Visual Symptoms (Visual Snow) Presenting as a Migraine Variant in a 12-Year-Old Girl
Pediatr Neurol 49:361-363, Simpson, J.C.,et al, 2013
Vestibular Migraine
Neurol 79:1607-1614, Radtke, A.,et al, 2012
Migraine
Lancet 363:381-391, Silberstein,S.D., 2004
The Interrelations of Migraine, Vertigo, and Migrainous Vertigo
Neurol 56:436-441,428, Neuhauser,H.,et al, 2001
Familial Acephalgic Migraines
Neurol 48:776-777, Shevell,M.I., 1997
Recurrent Neck Pain as a Variant of Migraine:Description of Four Cases
JNNP 62:669-670, DeMarinis,M.&Accornero,N., 1997
Recurrent Neck Pain as a Variant of Migraine:A Case Report
Neurol 46:269-270, DeMarinis,M., 1996
Familial Acephalgic Migraine
Neurol 45:2293-2294, Ziegler,D.K., 1995
Benign Episodic Unilateral Mydriasis
Ophthalmol 102:1623-1627, Jacobson,D.M., 1995
Amaurosis Fugax and Ocular Infarction in Adolescents and Young Adults
Ann Neurol 26:69-77, Tippin,J.,et al, 1989
Amaurosis Fugax in Teenagers, A Migraine Variant
Am J Dis Child 142:331-333, Appleton,R.,et al, 1988
The Fortification Spectra of Migraine
BMJ 293:1613-1617, Plant,G.T., 1987
Migrainous Olfactory Hallucinations
JNNP 50:1688-1690, Fuller,G.N.&Guiloff,R.J., 1987
Late-Life Migraine Accompaniments-Further Experience
Stroke 17:1033-1042, Fisher,C.M., 1986
The Terminology of Transient Visual Loss Due to Vascular Insufficiency
Stroke 15:907-908, Hedges,T.R., 1984
Benign Recurrent Vertigo
JNNP 42:363-367, Slater,R., 1979
Migraine Presenting as Acute Confusion & Delirium:A Case Report
Neurol 28:1201, Finelli,P.F., 1978
Current Concepts in the Diagnosis & Treatment of Chronic Recurring Headache
Med Clin North Am 56:l257, 1972 Nov., Friedman,A., 1972
Complicated Migraine
In Handbook of Clinical Neuro. , Ed. Vinken & Bruyn-5:Chap 6 N. Holland Pub. Co., Bruyn,G.W., 1968
Migraine without Headache
Lancet 283, 1967 Aug., Whitty,C.W., 1967
Hemiplegic Migraine, A Clinical Study
Quart J Med 65, 1965 Jan., Bradshaw,P.,et al, 1965
Mirror Writing (Book)
Psyche Miniatures Med. Series1928., Critchley,M., 1928
Genetic Causes of Cerebral Small Vessel Diseases, A Parctical Guide for Neurologists
Neurol 100:766-783, Manini,A.,&Pantoni,L., 2023
Atogepant for the Preventive Treatment of Chronic Migraine (PROGRESS): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial
Lancet 402:775-785, Pozo-Rosich,P.,et al, 2023
Acute Treatment for Migraine
JAMA 325:2346-2347, Burch, R. & Rayhill, M., 2021
Atogepant for the Preventive Treatment of Migraine
NEJM 385:695-706, Ailani,J.,et al, 2021
Burning Pain in the Legs
NEJM 383:e18, Sacks, C.A., 2020
One-Year Sustained Efficacy of Erenumab in Episodic Migraine
Neurol 95:e469-e479, Goadsby, P.J.,et al, 2020
Migraine
NEJM 383:1866-1876, Ashina, M., 2020
Migraine, hearing loss, and blurred vision in a young woman
Neurol 95:e2945-e2950, Sasikumar, S.,et al, 2020
Factors Associated with Risk of Recurrent Transient Global Amnesia
JAMA Neurol 77:1551-1558, Morris, K.A.,et al, 2020
Encephalopathy in a Large Cohort of British Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Patients
Stroke 50:283-290, Drazyk, A.M.,et al, 2019
A Woman in her 40s with Transient Neurological Symptoms, Migraine Headaches, and Hearing Loss
JAMA Neurol 76:504-505, Roshal, D.A.,et al, 2019
Erenumab in Chronic Migraine
Neurol 92:e2250-e2260, Lipton, R.B.,et al, 2019
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019
Remigepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine
NEJM 381:142-149, Lipton, R.B.,et al, 2019
Treatment Effects and Comorbid Diseases in 58 Patients with Visual Snow
Neurol 93:e398-e403, vanDongen, R.M.,et al, 2019
Acute Treatment of Migraine in Children and Adolescents
Neurol 93:487-499, Oskoui, M.,et al, 2019
Pharmacologic Treatment for Pediatric Migraine Prevention
Neurol 93:500-509, Oskoui, M.,et al, 2019
Fremanezumab versus Placebo for Migraine Prevention in Patients with Documented Failure to Up to Four Migraine Preventive Medication Classes (FOCUS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3� Trial
Lancet 394:1030-1040, Ferrari, M.D.,et al, 2019
Acute Vestibular Migraine Treatment with Noninvasive Vagus Nerve Stimulation
Neurol 93:e1715-e1719, Beh, S.C. & Friedman, D.I., 2019
Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019
Ubrogepant for the Treatment of Migraine
NEJM 381:2230-2241, Dodick, D.W.,et al, 2019
Noninvasive Vagus Nerve Stimulation as Acute Therapy for Migraine
Neurol 91:e364-e373, Tassorelli,C., et al, 2018
Preventive Migraine Drug Approved
JAMA 320:1746, , 2018
Efficacy and Tolerability of Erenumab in Patients with Episodic Migraine in Whom Two-of-Four Previous Preventive Treatments were Unsuccessful: A Randomised, Double-Blind, Placebo-Controlled, Phase 3b Study
Lancet 392:2280-2287,2241, Reuter, U.,et al, 2018